Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial on Pharmacokinetics and Tolerability of AP707

NCT05267769 is registered in ClinicalTrials.gov with CannaXan GmbH as lead sponsor.

NCT NCT05267769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05267769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial on Pharmacokinetics and Tolerability of AP707
Lead sponsor
CannaXan GmbH
Phase
Phase 1
Overall status
Completed
Start date
March 2, 2022
Completion date
April 3, 2022
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics, safety, tolerability